Which of the following manifestations are associated with primary Sjögren's syndrome: corneal ulceration, Fanconi syndrome, lymphoma, amyloidosis, or dental caries?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 6, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Primary Sjögren's Syndrome Manifestations

Primary Sjögren's syndrome may manifest as lymphoma (c), amyloidosis (d), and dental caries (e), with corneal ulceration (a) being a recognized ocular complication, while Fanconi syndrome (b) is not a typical manifestation of this disease.

Evidence-Based Analysis of Each Manifestation

Lymphoma (c) - CONFIRMED

The most recent 2024 Ophthalmology guidelines clearly establish that primary Sjögren's syndrome carries a significantly increased risk of lymphoid malignancy 1. Specifically:

  • Approximately 5% of patients with Sjögren's syndrome will develop some form of lymphoid malignancy 1
  • A meta-analysis found primary Sjögren's syndrome has an incidence rate of lymphoma of 18.9% (95% CI, 9.4–37.9), representing an increased incidence of 320 cases per 100,000 patient-years 1
  • Among rheumatic diseases, primary Sjögren's syndrome is the risk factor most strongly associated with lymphoid malignancy 1
  • This represents a 44-fold increased risk compared to the healthy population 2

Clinical implication: This is a potentially life-threatening complication requiring vigilant monitoring. Ophthalmologists and rheumatologists should maintain a high index of suspicion, particularly in patients with decreased C4 levels at diagnosis, recurrent parotid changes, lymph node enlargement, skin vasculitis, peripheral neuropathy, anemia, and lymphopenia 1, 2.

Amyloidosis (d) - CONFIRMED

The 2024 guidelines explicitly state that amyloidosis can result in infiltration of the lacrimal gland and replacement of the secretory acini, leading to aqueous tear deficiency 1. While the evidence discusses amyloidosis primarily in the context of lacrimal gland involvement, it is listed among systemic conditions that can develop in association with Sjögren's syndrome.

Dental Caries (e) - CONFIRMED

Dental caries is a well-established manifestation of primary Sjögren's syndrome due to decreased salivary flow:

  • A 2020 population-based cohort study demonstrated patients with primary Sjögren's syndrome have a significantly increased risk of dental caries (adjusted incidence rate ratio 1.64, P < 0.001) 3
  • A 2026 systematic review and meta-analysis found patients with primary Sjögren's syndrome have fewer teeth (mean difference: -2.16) and significantly higher DMFT (decayed, missing, filled teeth) scores (mean difference: 4.72) and DMFS (decayed, missing, filled surfaces) scores (mean difference: 20.45) 4
  • The risk extends to multiple oral disorders including candidiasis (OR: 10.5), dysphagia (OR: 26.78), dysgeusia (OR: 17), stomatitis (OR: 2.65), angular cheilitis (OR: 6.31), and fissured tongue (OR: 11.72) 4

Clinical implication: The inflammatory infiltration of salivary glands leads to severe xerostomia, creating an environment conducive to dental disease. Patients require intensive preventive dental care and early recognition 4.

Corneal Ulceration (a) - CONFIRMED (with nuance)

While not listed as a primary manifestation in the guidelines, corneal ulceration is a recognized ocular complication:

  • A 2023 study specifically examined corneal ulceration/perforation in Sjögren's syndrome, finding it occurred in 46 eyes of 44 patients, with corneal ulceration being the first presenting sign in 26% of patients 5
  • The ulceration is often sterile (83% of cases) and typically peripheral in location (63%) 5
  • The 2024 guidelines mention that patients with Sjögren's syndrome may develop sterile keratitis as an ocular manifestation of immune dysfunction 1

Important caveat: This represents a severe ocular complication rather than a typical manifestation, but it is definitively associated with the disease.

Fanconi Syndrome (b) - NOT CONFIRMED

There is no evidence in the provided guidelines or research linking Fanconi syndrome to primary Sjögren's syndrome. Fanconi syndrome is a proximal renal tubular disorder that is not mentioned in any of the comprehensive reviews of Sjögren's syndrome manifestations.

Clinical Algorithm for Recognition

When evaluating for primary Sjögren's syndrome manifestations:

  1. Sicca symptoms (dry eyes, dry mouth) are the hallmark
  2. Screen for lymphoma risk factors: parotid swelling, lymphadenopathy, decreased C4 levels, vasculitis
  3. Assess oral health: dental caries, candidiasis, oral ulceration require preventive intervention
  4. Monitor for severe ocular complications: corneal ulceration, particularly if peripheral and sterile
  5. Evaluate for systemic infiltrative disease: including amyloidosis affecting lacrimal glands

Answer: c, d, and e are confirmed manifestations; a is a recognized complication; b is not associated with primary Sjögren's syndrome.

Related Questions

Are all of the following statements about Sjögren’s syndrome correct: (a) association with lymphoma and pseudolymphoma, (b) association with cryoglobulinemia, (c) anti‑Ro (SSA) and anti‑La (SSB) antibodies are part of the diagnostic criteria, (d) the Schirmer test evaluates dry eyes?
Are Sjogren's syndrome and burning mouth disease the same condition?
I have Sjögren’s syndrome and experienced worsening submandibular (jaw) pain during a flight; what is the likely cause and how should I evaluate and treat it?
What is the recommended management for a patient with Sjögren’s syndrome presenting with keratitis?
Which of the following are extraglandular manifestations of Sjögren's syndrome: cutaneous purpuric vasculitis, xerostomia and xerophthalmia, parotid gland enlargement, glomerulonephritis, or interstitial nephritis?
Can a non‑contrast computed tomography (CT) of the adrenal glands be performed to assess adrenal insufficiency in a patient with a proven iodinated contrast allergy?
What is the maximum recommended daily dose of losartan for an adult patient?
What are the side effects of topical finasteride, particularly in a patient with a history of gynecomastia and erectile dysfunction from oral finasteride?
For an 8‑year‑old child currently taking atomoxetine who still has inadequate symptom control, should the atomoxetine dose be increased, and if so to what target dose, or should another medication be added?
In a patient with chronic mild hyponatremia who is not on a diuretic, has normal thyroid function (TSH) and is asymptomatic, what is the next step in management?
What is the recommended non‑invasive evaluation and management for a patient over 60 years old who declines endoscopy?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.